Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AIDA pseudogene 3 (AIDAP3) is annotated as a **pseudogene** in the human genome, indicating it is a DNA sequence similar to a known gene (in this case likely related to AIDA, the Axin Interactor, Dorsalization Associated gene), but considered non-functional due to sequence mutations preventing the production of a complete, active protein. Pseudogenes can sometimes regulate gene expression at the RNA level or act as "miRNA decoys," but there is currently no functional or disease relevance described for AIDAP3. It is not a receptor, enzyme, transporter, or other canonical drug target class. Its inclusion as a therapeutic target is therefore considered **incorrect**. - The entry may be **misspelled, misclassified, or not relevant** as a target for drug discovery or development, since pseudogenes generally lack protein-coding function and are not recognized as actionable therapeutic targets. - If you intended to inquire about the protein-coding gene **AIDA (Axin interactor, dorsalization associated)**, refer instead to that entry, which encodes a cytoplasmic protein involved in signaling, but not to "AIDA pseudogene 3".
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AIDA pseudogene 3 (AIDAP3).